Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
International Journal of Medicinal Mushrooms
Fator do impacto: 1.423 FI de cinco anos: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimir: 1521-9437
ISSN On-line: 1940-4344

Volumes:
Volume 22, 2020 Volume 21, 2019 Volume 20, 2018 Volume 19, 2017 Volume 18, 2016 Volume 17, 2015 Volume 16, 2014 Volume 15, 2013 Volume 14, 2012 Volume 13, 2011 Volume 12, 2010 Volume 11, 2009 Volume 10, 2008 Volume 9, 2007 Volume 8, 2006 Volume 7, 2005 Volume 6, 2004 Volume 5, 2003 Volume 4, 2002 Volume 3, 2001 Volume 2, 2000 Volume 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushr.v2.i1.40
7 pages

Peroral Effect on Tumor Progression of Soluble β-(1, 6)-Glucans Prepared by Acid Treatment from Agaricus blazei Murr. (Agaricaceae, Higher Basidiomycetes)

Yoshiaki Fujimiya
Division of Biotechnology, Sumitomo Forestry Tsukuba Research Institute, 3-2, Midorigahara, Tsukuba; and Department of Microbiology and Immunology, Hachinohe University School of Human Health Sciences, Hachinohe, Aomori 031-8566, Japan
Hajimu Yamamoto
Department of Clinical Nutrition, Suzuka University of Medical Science, Kishioka-cho, Suzuka, Japan
Masahide Noji
Department of Clinical Nutrition, Suzuka University of Medical Science, Kishioka-cho, Suzuka, Japan
Ikukatsu Suzuki
Faculty of Health Science, Suzuka University of Medical Science, 1001 Kishioka-cho Suzuka Mie 510-0293, Japan

RESUMO

Orally deliverable anticancer agents are becoming increasingly important in cost reduction of regimens for disorders that require protracted treatment and for patients' increasing preference and improved quality of life. The present study describes a simple procedure for the development of orally formulated anticancer agents of natural origin. The tumoricidal effects of natural products and purified extracts have previously been examined in single-grafted Meth-A tumor-bearing BALB/c mice by intratumoral injection of extracts from Agaricus blazei. Intratumoral administration of an ammonium oxalate-soluble/water- and ethanol-insoluble fraction 3, resulted in marked tumor regression, but continuous oral administration of feed containing fraction 3 from day 4 or 18 prior to tumor inoculation to day 21 after inoculation did not result in tumor regression. Intratumoral administration of fractions prepared by acid hydrolysis of either fraction 3 (ATF) or whole organisms (wATF) resulted in tumor regression almost identical to that seen using fraction 3. Oral administration of either soluble ATF or wATF also resulted in significant suppression of the progressive tumor, wATF being more active than ATF. ATF and wATF are composed predominantly of β-(1, 6)-glucans with apparent molecular masses of 10 kDa, with some unknown metabolite contamination (<20%). These results demonstrate that simple acid treatment of whole natural basidiomycetous products consisting mainly of β-(1, 6)-glucans can offer a valid approach to the development of anticancer agents that are orally effective, thus eliminating the need for multiple purification steps.